Emcure Pharmaceuticals Performance
- Today's Low
- ₹1,786
- Today's High
- ₹1,822
- 52 Week Low
- ₹1,260
- 52 Week High
- ₹1,944
- Open Price₹1,819
- Previous Close₹1,810
- Volume95,679
- 50 DMA₹1,750.55
- 100 DMA₹1,673.70
- 200 DMA₹1,574.02
Emcure Pharmaceuticals Chart
Investment Returns
- Over 1 Month + 3.12%
- Over 3 Month + 9.81%
- Over 6 Month + 13.99%
- Over 1 Year + 32.11%
Smart Investing Starts Here Start SIP with Emcure Pharmaceuticals for Steady Growth!
Emcure Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 36.7
- PEG Ratio
- 1
- Market Cap Cr
- 33,958
- P/B Ratio
- 6.9
- Average True Range
- 53.66
- EPS
- 49.88
- Dividend Yield
- 0.2
- MACD Signal
- 26.73
- RSI
- 49.83
- MFI
- 57.08
Latest Stock News Updates
Ownership consolidation follows the mRNA business carve-out as Emcure reshapes Gennova's strategy to sharpen its focus on biologics, biosimilars and adjacent therapeutic platforms
- Business Standard
- 2 days 1 hour ago
The rise in profits was attributed to the robust performance in international markets and growth in new launches from Emcure's in-house portfolio
- Business Standard
- 2 months 1 week ago
Conference Call with Emcure Pharmaceuticals Management and Analysts on Q4FY26 Performance and Outlook. Listen to the full earnings transcript.
- Trendlyne
- 2 months 1 week ago
Emcure Pharmaceuticals Financials
Emcure Pharmaceuticals Technicals
EMA & SMA
- Bearish Moving Average 8
- Bullish Moving Average 8
- 20 Day
- ₹1,802.30
- 50 Day
- ₹1,750.60
- 100 Day
- ₹1,673.70
- 200 Day
- ₹1,574.00
Resistance and Support
- R3 1,849.53
- R2 1,835.77
- R1 1,813.03
- S1 1,776.53
- S2 1,762.77
- S3 1,740.03
Emcure Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
About Emcure Pharmaceuticals
- NSE Symbol
- EMCURE
- BSE Symbol
- 544210
- Managing Director & CEO
- Mr. Satish Ramanlal Mehta
- ISIN
- INE168P01015
Similar Stocks to Emcure Pharmaceuticals
Popular Stocks
Emcure Pharmaceuticals FAQs
Emcure Pharmaceuticals share price is ₹1,790 As on 15 July, 2026 | 19:29
The Market Cap of Emcure Pharmaceuticals is ₹33958.4 Cr As on 15 July, 2026 | 19:29
The P/E ratio of Emcure Pharmaceuticals is 36.7 As on 15 July, 2026 | 19:29
The PB ratio of Emcure Pharmaceuticals is 6.9 As on 15 July, 2026 | 19:29
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.